Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR)

May 3 – 7, 2008
Toronto, Canada

As the incoming President of ISPOR, Chris Pashos, Ph.D., Vice President Abt Bio-Pharma Solutions, addressed the conference on Tuesday, May 6.

Abt Bio-Pharma Solutions was both an exhibitor at the conference and an event sponsor.

Abt Bio-Pharma Solutions lead a four-hour Patient Registries Short Course on Sunday May 4 and several members of staff made presentations during the conference:

Monday, May 5

PATIENT REGISTRY SIG FORUM

Registry Design, Operations, Data & Taxonomy
This session focused on good research principles, practical design and operational considerations in developing registries and the use of patient registry information as well as the ISPOR Taxonomy of Patient Registries book.
Speakers (Patient Registry SIG Working Group Chairs):
Chris L. Pashos, Ph.D., Vice President, ABS
Leanne R. Larson, M.H.A. Vice President, Registry Consulting, Ovation Research Group / ICON Clinical Research
Annette Stemhagen, Dr.P.H., F.I.S.P.E., Vice President, Epidemiology and Risk Management, United BioSource Corporation

PODIUM PRESENTATIONS - SESSION III

Cardiovascular Disease Outcomes Research

Clinical and Economic Outcomes Associated With Bleeding During Coronary Artery Bypass Graft Surgery Among Elderly Americans
Ganz, M.L., Pashos, C.L., Abt Bio-Pharma Solutions
Joshi, A.V., Novo Nordisk
Wang, Q., Lee, W.C., Abt Associates
Wilke, C.T., University of Illinois at Chicago

Tuesday, May 6

ISPOR Fellowship Standards Task Force Forum

Pharmacoeconomic and Outcomes Research Fellowship Standards

This Forum provided an opportunity to discuss the upcoming publication of the Task Force report Joint ACCP and ISPOR Guidelines for Pharmacoeconomic and Outcomes Research Fellowship Training Programs.  Several PEOR fellowship mentors and their fellows briefly discussed their experiences and its relationship to the Fellowship Guidelines.  A floor discussion was open to all participants, including fellows, preceptors of fellows, academics and other interested parties, to meet and share their thoughts and ideas about Pharmacoeconomic fellowships.
Moderator: Alan Bakst, Pharm.D., M.B.A., Chair, ISPOR Fellowship Standards Task Force and Senior Director, Global Health Economics and Reimbursement, Baxter Healthcare Corporation,
Speakers:
Svetlana Denevich, Pharm.D., Pharmacoeconomics and Outcomes Research Fellow, ABS
Shiraz Gupta, Pharm.D., Manager, Global Health Economics & Outcomes Research
A. Simon Pickard, Ph.D., Assistant Professor, Pharmacy Practice & Pharmacy Administration, Assistant Director, Center for Pharmacoeconomic Research, College of Pharmacy, University of Illinois
Prabashni Reddy, R.Ph., M.S., Pharm.D., Director of the Center for Drug Policy, Partners Healthcare
Robert Wittenberg, Pharm.D., Fellow, University of Illinois at Chicago & TAP Pharmaceutical Products

POSTER PRESENTATIONS

Clinical Outcomes and Drug Cost In Erythropoiesis-Stimulating Agent (ESA)-Treated Cancer Chemotherapy Patients Initiated With Baseline (BL) Hemoglobin
Burton, T., Larholt, K., Hoaglin, D., Pashos, C.L., Bookhart, B., Corral, M., McKenzie, R.S., Tak Piech, C.

The Perspective of Patients with Hemophilia with Inhibitors and Their Care Givers: Preferences for Treatment Characteristics
Lee, W.C., Ashish V., Brown, M., Joshi, A.V., Foster, T., Pashos, C.L.

Health-related quality of life of patients with hemophilia and inhibitors
Lee, W.C., Brown, M., Joshi, A.V., Foster, T., Pashos, C.L.

Economic evaluation of sorafenib versus best supportive care in advanced renal cell carcinoma: an updated cost-effectiveness analysis
Gao, X., Shah, S., Reddy, P., Gondek, K., Pashos, C.L.

Substance abuse among patients diagnosed with insomnia
Boulanger, L., Doan, J., Pashos, C.L.

Does the dosing frequency of proton pump inhibitors (PPIs) affect subsequent resource utilization and costs among patients diagnosed with gastroesophageal reflux disease (GERD)?
Boulanger, L., Mody, R., Bao, Y., Ancukiewicz, V., Kothari-Talwar, S., Russell, M.W.

Economic impact of stroke-related comorbid conditions on the treatment of stroke: an analysis of Medicare beneficiaries in the United States
Lee, W.C., Pickard, S., Wilke, C., Joshi, A.V., Yeh, Y.C., Wang, Q., Pashos, C.L.

Gender disparities in the utilization of myocardial perfusion imaging
Spalding, J., Gao, X., Denevich, S., Reddy, P.

Factors associated with healthcare costs among elderly patients with diabetic neuropathy
Boulanger, L., Zhao, Y., Bao, Y., Cai, C., Ye, W., Russell, M.W.

Cost-Utility of Interferon Beta-1b in the Treatment of Patients with a Clinically Isolated Syndrome Suggestive of Multiple Sclerosis
Caloyeras, J.P., Wang, C. (Bayer HealthCare, Montville, New Jersey), Bauer, L. (Bayer Schering Pharma AG, Berlin), Lee, W.C., Lanius, V.(Bayer Schering Pharma AG, Berlin), Gondek, K.

For more information, visit the ISPOR 2008 Website.